At Gliolab, we help you and your doctor discover treatment paths designed uniquely for you — based on your tumor profile.
Genomic testing is crucial for uncovering a tumor’s unique molecular profile, identifying targeted therapies, and guiding evidence-based clinical decisions. Our goal is to ensure that every patient receives all three essential tests—Whole Genome DNA Methylation, Comprehensive Genomic Profiling, and Archer FusionPlex—regardless of their insurance coverage.
This comprehensive testing framework does more than provide data; it builds a personalized treatment roadmap tailored to each patient’s tumor biology. Rather than relying on one-size-fits-all protocols, care teams can use our detailed genomic insights to pinpoint therapies most likely to be effective, explore relevant clinical trials, and avoid unnecessary treatments.
With Gliolab, patients and their physicians gain clarity, direction, and a powerful tool for navigating one of the most complex and aggressive brain cancers.
Your Journey. Your Plan.
Personalized Glioblastoma Care Starts at Gliolab.
Tier 1: Philanthropy-Supported Testing
For patients without insurance:
- No patient should be denied access to potentially life-saving information. Gliolab provides genomic testing at no cost to uninsured patients. This is made possible through the generosity of donors and philanthropic partners who share our commitment to personalized care.
Tier 2: Reduced Co-Pay Option
For patients with Medicare:
- For medicare-covered tests, most patients will have zero out-of-pocket costs.
- For tests not covered by medicare, patients may have some out-of-pocket expenses. Our team will help you determine what your out-of-pocket costs will be.
Tier 3: Standard Co-Pay Option
For patients with private insurance or other coverage:
- Depending on the terms of your insurance plan, you may have financial responsibility for a co-pay, co-insurance, or a deductible as directed by your plan. Our team will help you determine what your out-of-pocket costs will be.
